NCT05618145 National Database on Primary Sclerosing Cholangitis (PSC)
| NCT ID | NCT05618145 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Milano Bicocca |
| Condition | Primary Sclerosing Cholangitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2022-10-21 |
| Primary Completion | 2032-10-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2022-10-21 with a primary completion date of 2032-10-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Primary sclerosing cholangitis (PSC) a rare, chronic fibroinflammatory disease of the liver. No data about the disease epidemiology exist in Italy. Therefore this study aims to develop a national PSC patient database linked to a biological sample storage.
Eligibility Criteria
Inclusion Criteria: * Willing and able to give informed consent prior to any study specific procedure being performed; * Diagnosis of PSC according to the most recent published guidelines (EASL); Exclusion Criteria: * Subject unwilling to participate at the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05618145 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, studying Primary Sclerosing Cholangitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05618145 currently recruiting?
Yes, NCT05618145 is actively recruiting participants. Contact the research team at pietro.invernizzi@unimib.it for enrollment information.
Where is the NCT05618145 trial being conducted?
This trial is being conducted at Ancona, Italy, Bari, Italy, Bergamo, Italy, Bergamo, Italy and 11 additional locations.
Who is sponsoring the NCT05618145 clinical trial?
NCT05618145 is sponsored by University of Milano Bicocca. The trial plans to enroll 6,000 participants.